Altogether, these findings suggest that MT1-MMP may reduce HDL levels through cleaving plasma apoA-I and increase LDL and remnant cholesterol levels via cleaving hepatic LDLR and plasma apoE, respectively, thereby increasing the risk of atherosclerosis. The gene discussed is MMP14; the disease is atherosclerosis.